Teva to Host Conference Call to Discuss Fourth Quarter 2025

Teva to Host Conference Call to Discuss Fourth Quarter 2025

TEL AVIV, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter 2025 financial results on Wednesday, January 28, 2026, at…

Continue Reading